News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
256,643 Results
Type
Article (5933)
Company Profile (27)
Press Release (250683)
Multimedia
Podcasts (3)
Webinars (5)
Section
Business (87698)
Career Advice (473)
Deals (16488)
Drug Delivery (10)
Drug Development (21248)
Employer Resources (32)
FDA (4055)
Job Trends (4567)
News (129815)
Policy (8421)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (350)
Accelerated approval (12)
ADA (11)
Adcomms (4)
Allergies (27)
Alliances (16226)
ALS (59)
Alzheimer's disease (419)
Antibody-drug conjugate (ADC) (92)
Approvals (4227)
Artificial intelligence (164)
ASCO (56)
Autoimmune disease (77)
Automation (13)
Bankruptcy (107)
Best Places to Work (3389)
Biosimilars (41)
Biotechnology (29)
Bladder cancer (49)
Brain cancer (18)
Breast cancer (180)
Cancer (1342)
Cardiovascular disease (93)
Career advice (406)
Career pathing (4)
CAR-T (82)
CDC (4)
Celiac Disease (1)
Cell therapy (215)
Cervical cancer (8)
Clinical research (18967)
Collaboration (538)
Compensation (491)
Complete response letters (14)
COVID-19 (467)
CRISPR (19)
C-suite (525)
Cystic fibrosis (30)
Data (2059)
Denatured (2)
Depression (32)
Dermatology (24)
Diabetes (124)
Diagnostics (2428)
Digital health (14)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (72)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (55)
Earnings (45977)
Editorial (5)
Employer branding (6)
Employer resources (34)
Events (42876)
Executive appointments (515)
FDA (5020)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (478)
Gene editing (33)
Generative AI (8)
Gene therapy (125)
GLP-1 (182)
Government (538)
Guidances (211)
Healthcare (5659)
Hematology (53)
HIV (15)
Huntington's disease (8)
IgA nephropathy (26)
Immunology and inflammation (48)
Immuno-oncology (19)
Indications (39)
Infectious disease (513)
Inflammatory bowel disease (38)
Inflation Reduction Act (3)
Influenza (10)
Intellectual property (45)
Interviews (57)
IPO (8482)
IRA (3)
Job creations (1260)
Job search strategy (366)
JPM (4)
Kidney cancer (14)
Labor market (14)
Layoffs (119)
Leadership (7)
Legal (2679)
Liver cancer (22)
Longevity (5)
Lung cancer (144)
Lymphoma (97)
Machine learning (11)
Management (11)
Manufacturing (231)
MASH (62)
Medical device (4407)
Medtech (4451)
Mergers & acquisitions (8544)
Metabolic disorders (308)
mRNA (17)
Multiple sclerosis (28)
NASH (6)
Neurodegenerative disease (89)
Neuropsychiatric disorders (15)
Neuroscience (791)
NextGen: Class of 2026 (1792)
Non-profit (798)
Now hiring (7)
Obesity (120)
Opinion (35)
Ovarian cancer (45)
Pain (42)
Pancreatic cancer (82)
Parkinson's disease (80)
Partnered (12)
Patents (85)
Patient recruitment (155)
Peanut (6)
People (27541)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase 1 (5638)
Phase 2 (8371)
Phase 3 (6551)
Pipeline (3477)
Policy (25)
Postmarket research (658)
Preclinical (2218)
Press Release (67)
Prostate cancer (85)
Psychedelics (5)
Radiopharmaceuticals (150)
Rare diseases (251)
Real estate (2029)
Recruiting (9)
Regulatory (6333)
Reports (19)
Research institute (360)
Resumes & cover letters (69)
Rett syndrome (28)
RNA editing (5)
RSV (2)
Schizophrenia (68)
Series A (73)
Series B (71)
Service/supplier (2)
Sickle cell disease (18)
Special edition (1)
Spinal muscular atrophy (39)
Sponsored (7)
Startups (1134)
State (1)
Stomach cancer (1)
Supply chain (23)
Tariffs (7)
The Weekly (1)
Vaccines (128)
Venture capital (16)
Weight loss (43)
Women's health (12)
Worklife (1)
Date
Last 7 days (157)
Last 30 days (674)
Last 365 days (9987)
2026 (5012)
2025 (10075)
2024 (12201)
2023 (14500)
2022 (20417)
2021 (21836)
2020 (19694)
2019 (14287)
2018 (10996)
2017 (10864)
2016 (9992)
2015 (13150)
2014 (10359)
2013 (8347)
2012 (9039)
2011 (9442)
2010 (9255)
Location
Africa (201)
Alabama (20)
Alaska (2)
Arizona (92)
Arkansas (2)
Asia (12686)
Australia (1799)
California (4520)
Canada (2104)
China (235)
Colorado (183)
Connecticut (219)
Delaware (94)
Europe (27527)
Florida (708)
Georgia (100)
Idaho (25)
Illinois (221)
India (30)
Indiana (181)
Iowa (9)
Japan (252)
Kansas (43)
Kentucky (21)
Louisiana (12)
Maine (57)
Maryland (432)
Massachusetts (3673)
Michigan (154)
Minnesota (269)
Mississippi (1)
Missouri (40)
Montana (18)
Nebraska (14)
Nevada (63)
New Hampshire (27)
New Jersey (1514)
New Mexico (8)
New York (1127)
North Carolina (625)
North Dakota (5)
Northern California (2407)
Ohio (145)
Oklahoma (9)
Oregon (7)
Pennsylvania (866)
Puerto Rico (4)
Rhode Island (20)
South America (311)
South Carolina (20)
Southern California (1696)
Tennessee (85)
Texas (723)
United States (16462)
Utah (148)
Vermont (1)
Virginia (110)
Washington D.C. (17)
Washington State (395)
West Virginia (2)
Wisconsin (88)
Wyoming (2)
256,643 Results for "intelgenx corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zenith Capital Corp. Amends Promissory Notes
May 12, 2026
·
6 min read
Press Releases
Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery.
Combining human iPSC biology and AI computing to accelerate drug discovery, improve drug safety, and advance precision medicine.
June 19, 2026
·
1 min read
Studies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® Platform
IntelGenx Corp. announced positive results from a proof-of-concept study to assess the palatability, owner-perceived acceptability, and ease of repeated administration of IntelGenx’s VetaFilm® platform in healthy dogs and cats.
February 5, 2024
·
4 min read
Press Releases
CORRECTION FROM SOURCE: Entheon Biomedical Corp. Issues Correction to News Release Dated June 9, 2026
June 10, 2026
·
1 min read
Press Releases
NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University
June 9, 2026
·
4 min read
Press Releases
Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading
May 5, 2026
·
14 min read
Press Releases
Resverlogix Corp. Announces Issuance of MCTO by ASC
April 2, 2026
·
4 min read
Press Releases
Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
April 16, 2026
·
2 min read
Business
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the three- and twelve-month periods ended December 31, 2023.
March 21, 2024
·
7 min read
Press Releases
Scryb Inc. Changes Name to NorthPalm Capital Corp. and Announces New Trading Symbols
May 5, 2026
·
2 min read
1 of 25,665
Next
